Skip to content
Three pipettes with colored liquides, one is lifted up by a hand wearing blue gloves.

Up to two research calls per year

Research grants

Currently, the majority of our funding is awarded via research grants to academic institutions, although consortia including industry are welcome to apply.

Usually, two scheduled calls for research proposals are held each year. They can either be ‘All priorities’ calls which means that project topics should fit within one or more of EB-ResNet’s four strategic research priorities. Alternatively, a scheduled ‘Special’ call may be issued to invite proposals to address identified important unmet research questions, technology needs or clinical consequences arising from EB (e.g. chronic inflammation and fibrosis).

Project scope 'Research grants'

  • Fundamental to preclinical research, and clinical trials projects in EB
  • Research projects must fall into the scope of a current research call: either an 'All priorities' call or a 'Special call' i.e. chronic inflammation and fibrosis
  • Lead applicant: researchers and/or clinicians (cooperation with industry welcome and possible)
  • Project duration: 12 to 36 months
  • Funding: up to EUR 90,000.00 p.a.

General information: application and funding process

Funded projects (EB-ResNet & DEBRA International research calls)

Grant Round/

Call

 

Project lead

Organisation/

Institute

Duration Research area EB-type Funder(s)
CIF Call 2018 Prof. Giovanna Zambruno

Bambino Gesu Ospedale,

Italy

3 years

Clinical research

RNA-therapy Fibrosis

Dystrophic

 

DEBRA Austria

DEBRA UK

DEBRA Spain

CIF Call 2018 Prof. Ulrich Rodeck

Thomas Jefferson University,

USA

2 years

Clinical researh

Small molecules

Fibrosis

Dystrophic

DEBRA Austria

DEBRA Ireland

CIF Call 2018 Dr. Yanling Liao

New York Medical College,

USA

3 years

Clinical research

Cancer

Dystrophic

DEBRA UK

DEBRA Ireland

All Priorities 2019 Prof. Valerie Brunton

University of Edinburgh,

UK

3 years

Fundamental research 

Cancer

Kindler

DEBRA Austria

DEBRA UK

All Priorities 2019 Prof. Karine Raymond

Leiden University Medical Center,

The Netherlands

3 years

Fundamental research

Pluripotent stem cells

Simplex

DEBRA Austria

All Priorities 2019 Dr. Colin Butler

University College London,

Great Ormond Street Institute

of Child Health,

UK

2 years

Fundamental research

Cellular and molecular therapy

Junctional

DEBRA Austria

DEBRA UK

All Priorities 2019 Prof. Liam Grover

University of Birmingham,

UK

2 years

Preclinical research

Small molecules

Dystrophic DEBRA UK

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

Innovative Research

Grant Call 2017

Dr. Cédric Gaggioli

Projectdetails

Association pour le Développement

des Sciences Médicales,

Faculté de Médicine,

France

1 year

Fundamental research

Small molecules

Dystrophic DEBRA Austria

All Priorities

Call 2018

Prof. Jouni Uitto

Projectdetails

Thomas Jefferson University,

USA

2 years

Fundamental research

Molecular diagnostics

Dystrophic

Junctional

Simplex

DEBRA Austria

All Priorities

Call 2018

Prof. Ganna Bilousova

University of Colorado,

USA

3 years

Fundamental research

Cellular and molecular

therapy

Dystrophic DEBRA Austria

All Priorities

Call 2018

Dr. Su Lwin

Projectdetails

Kings College London,

UK

2 years

Gene therapy

SSC

Dystrophic DEBRA UK

All Priorities

Call 2018

Prof. Gareth Inman

Projectdetails

University of Glasgow 1 year SSC Dystrophic DEBRA UK

All Priorities

Call 2018

Prof. Iain Chapple

Projectdetails

University of Birmingham 3 years EB biology All types DEBRA UK

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2017

Prof. Cristina Has

Projectdetails

University of Freiburg,

Germany

1 year

Fundamental research

Genetics

Simplex DEBRA Austria

All Priorities

Call 2017

Dr. Antonia Reimer

Projectdetails

University of Freiburg,

Germany

3 years

Fundamental research

Clinical characterization

Dystrophic

Junctional

DEBRA Austria

Innovative Research

Grant Call 2017

Prof. Margarita Calvo

Projectdetails

Pontificia Universidad

Católica de Chile,

Chile

1,5 years

Fundamental research

Small molecules

Symptom relief

Dystrophic

DEBRA Austria

 

All Priorities

Call 2017

Prof. Daniele Castiglia

Projectdetails

IRCCS, Rome,

Italy

3 years

Fundamental research

Small molecules

Woundhealing

Dystrophic

DEBRA Austria

DEBRA UK

All Priorities

Call 2017

Prof. Thomas Magin

Projectdetails

University of Leipzig,

Germany

3 years

Fundamental research

Small molecules

Simplex DEBRA Austria

All Priorities

Call 2017

Prof. Alain Hovnanian

Projectdetails

INSERM, Departement of Genetics,

France

2 years

Fundamental research

Cellular and molecular

therapy

Dystrophic DEBRA Austria
CliniCall 2015 Prof. Peter Marinkovich Stanford University, USA 3 years

Clinical trial Phase II

Cellular and molecular

therapy

Dystrophic DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2016

Dr. Fernando Larcher

Projectdetails

CIEMAT - Centro de Investigaciones

Energéticas Medioambientales y

Tecnológicas Prospósito, SPAIN

2 years

Molecular therapy,

Cellular therapy

Dystrophic DEBRA Austria

All Priorities

Call 2016

Prof. Arnoud Sonnenberg

Projectdetails

Netherlands Cancer Institute,

THE NETHERLANDS

2 years

Molecular therapy,

Cellular therapy

Dystrophic

DEBRA Austria

All Priorities 

Call 2016

Prof. Jouni Uitto

Projectdetails 

Thomas Jefferson University,

Philadelphia,

USA

2 years

EB genetics,

epigenetics & biology

Simplex

Dystrophic

Junctional

 

DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2015

Dr. Andrew South

Projectdetails

Thomas Jefferson University,

Philardelphia,

USA

2 years

Molecular therapy,

cellular therapy

Dystrophic DEBRA Austria

All Priorities

Call 2015

Dr. Marius Wernig

Projectdetails

Standord University, California,

USA

3 years Molecular therapy Dystrophic DEBRA Austria

All Priorities 

Call 2015

Prof. Leena Bruckner-

Tuderman

University of Freiburg Medical Center,

Departement of Determatology,

GERMANY

4 years Clinical trial Phase II Dystrophic DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2014

Prof. Mitchell Cairo

Projectdetails

New York Medical College,

New York, USA

2 years (+ 1) Cellular therapy Dystrophic DEBRA Austria

All Priorities

Call 2014

Prof. Crstina Has

Projectdetails

University of Freiburg Medical Center,

Departement of Dermatology,

GERMANY

2 years

EB genetics, epigenetics

& biology

Simplex DEBRA Austria

All Priorities 

Call 2014

Dr. Mark Saville

Projectdetails

Ninewells Hospital and Medical School,

University of Dundee, UK

3 years Skin cancer & fibrosis Dystrophic DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2013

Dr. Iris Gratz

Projectdetails

University of Salzburg,

Departement of Molecular Biology,

AUSTRIA

2 years

Molecular therapy,

cellular therapy,

immunology

Dystrophic DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

3MEuro Call

2012

Prof. Leena Bruckner-

Tuderman

University Freiburg Medical Center,

Departement of Determatology,

GERMANY

2 years

 

  DEBRA Austria

3MEuro Call

2012

Prof. Ellen Brigitte Lane

IMB - Institute of Medical Biology,

SINGAPORE

2 years

 

 

DEBRA Austria

3MEuro Call

2012

Prof. Peter Marinkovich

Stanford University, California,

USA

3 years

 

 

 

DEBRA Austria

3MEuro Call

2012

Dr. Waseem Qasim

Molecular Immunology Unit 

UCL Institute of Child Health, London,

UK

3 years     DEBRA Austria

3MEuro Call

2012

Prof. Dennis Roop

University of Colorade, Denver,

USA

3 years     DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities 

Call 2011

Prof. Leena Bruckner-

Tuderman

Projectdetails

University Freiburg Medical Center,

Departement of Dermatology, 

GERMANY

3 years+1

Symptom prevention & relief

Dystrophic DEBRA Austria

All Priorities 

Call 2011

Prof. Johann Bauer

Projectdetails

PMU, Salzburg,

AUSTRIA

3 years

Molecular therapy,

cellular therapy

 

DEBRA Austria

All Priorities 

Call 2011

Prof. Mitchell Cairo

Projectdetails

New York Medical College,

New York, USA

2 years +1

Molecular therapy,

cellular therapy

Dystrophic

 

DEBRA Austria

All Priorities 

Call 2011

Prof. Ellen Brigitte Lane

Projectdetails

IMB - Institute of Medical Biology,

SINGAPORE

3 years Molecular therapy Simplex DEBRA Austria

All Priorities 

Call 2011

Dr. Derry Charles Roopenian

Projectdetails

The Jackson Laboratory, 

Bar Harbor, Main,

USA

1 year

EB genetics, epigenetics

& biology

Junctional DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2010

Dr. Cedric Gaggioli

A.D.S.M. Association pour le Développment des

Sciences Médicales, Faculté de Médicine, Nice,

FRANCE

1 year     DEBRA Austria

All Priorities 

Call 2010

Prof. John McGrath

Projectdetails

King's College London, School of Medicine,

St. John's Institute of Dermatology, UK

2 years + 9 months

Symptom prevention

& relief

Dystrophic DEBRA Austria

All Priorities 

Call 2010

Dr. Alessandra Recchia

Projectdetails

Centre fro regenerative Medicine,

University of Modena and Reggio Emilia,

ITALY

2 years

Molecular therapy,

cellular therapy

Dystrophic

DEBRA Austria

All Priorities 

Call 2010

Prof. Dennis Roop

University of Colorado, Denver,

USA

2 years    

 

DEBRA Austria

All Priorities 

Call 2010

Prof. John Sundberg

The Jackson Laboratory, Bar Harbor, 

USA

4 months     DEBRA Austria

All Priorities 

Call 2010

Dr. Jakub Tolar

University of Minnesota, Departement of

Pediatric Hermatology - Oncology / Blood

and bone Marrow Transplantation, 

USA

2 years     DEBRA Austria

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2009

Prof. Mitchell Cairo

Columbia University,

Departement of Medicine and Pathology,

New York, USA

1 year     DEBRA Austria

All Priorities 

Call 2009

Dr. Laurent Gagnoux-Palacios

A.D.S.M. Association pour le Développement

des Sciences Médiacles, Faculté de Médicine,

Nice, FRANCE

3 years

 

  DEBRA Austria

All Priorities 

Call 2009

Prof. Josef Penninger

Projectdetails

IMBA Institute of Molecular Biotechnology,

Vienna,

Austria

2 years + 6 months

 

Cellular therapy
Dystrophic DEBRA Austria

All Priorities 

Call 2009

Prof. Colin Johada

Durham University, School of Biological and

Biomedical Sciences, Durham, UK

2 years    

 

DEBRA Austria

All Priorities 

Call 2009

Dr. John F. Marshall

Queen Mary University of London, Barts and

London Medical School, Institute of Cancer,

Centre for Tumour Biology, London, UK

2 years     DEBRA Austria

All Priorities 

Call 2009

Dr. Andrew South

Ninewells Hospital and Medical School,

Centre for Oncology and Molecular Medicine,

Dundee, UK

1 year     DEBRA Austria

All Priorities 

Call 2009

Dr. Wensin Wang

NUIG National University of Ireland,

Galway, Department of Mechanical and

Biomedical Engineering, Galway, IRELAND

1,5 years      

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2007

Prof. Peter Marinkovich

Stanford University, California,

USA

1 year     DEBRA Austria

All Priorities

Call 2007

Dr. Olga Igoucheva

Jefferson Medical College,

Departement of Dermatology and

Cutaneous Biology, hiladelphia,

USA

2 years     DEBRA Austria

 

Contact for Research grants

Portraitfoto von Gaston Sendin

Gaston Sendin, PhD

Head of Research
Back to main navigation
This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .